STEF 118.000 € (+0,85 %) CAPGEMINI 87.960 € (-2,85 %) MEDINCELL 28.640 € (+5,92 %) 
UNILEVER 52.650 € (-1,02 %) 
UMG 18.330 € (-0,87 %) KALRAY 8.760 € (+9,50 %) ASML HOLDING 1 721.400 € (+6,79 %) EUTELSAT COMMUNIC. 2.413 € (+7,20 %) TOTALENERGIES 68.030 € (-0,15 %) ABL Diagnostics 2.780 € (+11,20 %) SAFRAN 345.000 € (+2,53 %) BE SEMICONDUCTOR 287.100 € (+2,94 %) TOMTOM 4.642 € (+2,11 %) CSG 12.774 € (-1,51 %) 
DSM FIRMENICH AG 83.000 € (+1,69 %) RELX 27.580 € (+0,51 %) SANOFI 75.080 € (-0,56 %) ADVICENNE 1.250 € (-6,02 %) HERMES INTL 1 598.000 € (-1,08 %) HAVAS 17.050 € (-0,87 %) ARCADIS 33.620 € (+1,76 %) SODEXO 50.650 € (+0,20 %) EDENRED 22.500 € (+0,67 %) KPN KON 4.316 € (-2,60 %) LVMH 484.100 € (-1,67 %) DANONE 71.740 € (-0,42 %) UBISOFT ENTERTAIN 5.376 € (+1,43 %) VINCI 127.800 € (+0,75 %) SHELL PLC 34.065 € (+1,02 %) CROSSJECT 1.784 € (-3,25 %) BOLLORE 4.056 € (-1,07 %) FUGRO 9.450 € (-0,47 %) VALLOUREC 20.490 € (-1,11 %) PLUXEE 11.470 € (+2,87 %) ID LOGISTICS GROUP 342.000 € (0,00 %) PREDILIFE 2.300 € (-4,56 %) MON COURTIER ENERG 5.800 € (+3,57 %) ENGIE 27.590 € (+0,69 %) ROBERTET 806.000 € (-1,23 %) SAINT GOBAIN 79.160 € (+2,09 %) SOITEC 117.300 € (+2,62 %) BIC 57.000 € (-0,70 %) FSDV 18.600 € (0,00 %) VALNEVA 2.255 € (+1,81 %) MEMSCAP REGPT 4.640 € (+1,31 %) ADYEN 820.400 € (-1,04 %) KERING 247.300 € (-6,91 %) VICAT 63.500 € (+1,60 %) AKZO NOBEL 59.340 € (+0,41 %) AIR LIQUIDE 173.280 € (+0,32 %) VALEO 12.815 € (+3,81 %) CHRISTIAN DIOR 449.000 € (-1,49 %) SHOWROOMPRIVE 0.730 € (-0,27 %) PLANISWARE 18.180 € (-0,44 %) AXA 43.850 € (+1,06 %) CA TOULOUSE 31 CCI 130.060 € (-0,34 %) DASSAULT AVIATION 287.200 € (+1,27 %) BOUYGUES 48.810 € (+0,47 %) IMCD 79.000 € (-0,10 %) GECINA 73.550 € (-0,68 %) |
17/03/2023 13:00
Ra Medical Systems Announce Issuance of Additional International PatentFORT MILL, SC / ACCESSWIRE / March 17, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) today announced that its wholly owned subsidiary, Catheter Precision, Inc., has received notification of an additional issuance of a new international patent. The patent is part of the evolving number of patents surrounding the company's VIVO technology. The patent, entitled "Methods of Cardiac Mapping and Model Merging" has been issued in the country of Japan. RMED's Executive Chairman, David Jenkins, commented. "As a medical device company, we realize that intellectual property is a key part of growing not only our value but also our market presence. We are pleased that our technology in the field of cardiac electrophysiology continues to be recognized as unique and different. This patent combines with our entire estate of over fifty patents and patent applications covering our different product areas." About VIVO Catheter Precision's VIVO™ (View Into Ventricular Onset), is a non-invasive 3D imaging system that enables physicians to identify the origin of ventricular arrhythmias pre-procedure, thereby streamlining workflow and reducing procedure time. VIVO has received marketing clearance from the U.S. FDA and has the CE mark. About Ra Medical Systems Ra Medical, and its wholly owned subsidiary Catheter Precision, is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. CONTACTS: At the Company SOURCE: Ra Medical Systems, Inc. View source version on accesswire.com: https://www.accesswire.com/744254/Ra-Medical-Systems-Announce-Issuance-of-Additional-International-Patent Source : Webdisclosure.com |
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière